PT - JOURNAL ARTICLE AU - Bautin, Paul AU - Fortier, Marc-Antoine AU - Sean, Monica AU - Little, Graham AU - Martel, Marylie AU - Descoteaux, Maxime AU - Léonard, Guillaume AU - Tétreault, Pascal TI - What has brain diffusion MRI taught us about chronic pain: a narrative review AID - 10.1101/2023.03.03.23286579 DP - 2023 Jan 01 TA - medRxiv PG - 2023.03.03.23286579 4099 - http://medrxiv.org/content/early/2023/12/24/2023.03.03.23286579.short 4100 - http://medrxiv.org/content/early/2023/12/24/2023.03.03.23286579.full AB - Chronic pain is a pervasive and debilitating condition with increasing implications for public health, affecting millions of individuals worldwide. Despite its high prevalence, the underlying neural mechanisms and pathophysiology remain only partly understood. Since its introduction 35 years ago, brain diffusion MRI has emerged as a powerful tool to investigate changes in white matter microstructure and connectivity associated with chronic pain. This review synthesizes findings from 58 articles that constitute the current research landscape, covering methodologies and key discoveries.We discuss the evidence supporting the role of altered white matter microstructure and connectivity in chronic pain conditions, highlighting the importance of studying multiple chronic pain syndromes to identify common neurobiological pathways. We also explore the prospective clinical utility of diffusion MRI, such as its role in identifying diagnostic, prognostic, and therapeutic biomarkers.Further, we address shortcomings and challenges associated with brain diffusion MRI in chronic pain studies, emphasizing the need for the harmonization of data acquisition and analysis methods. We conclude by highlighting emerging approaches and prospective avenues in the field that may provide new insights into the pathophysiology of chronic pain and potential new therapeutic targets.Due to the limited current body of research and unidentified targeted therapeutic strategies, we are forced to conclude that further research is required. However, we believe that brain diffusion MRI presents a promising opportunity for enhancing our understanding of chronic pain and improving clinical outcomes.Competing Interest StatementMD is co-founder of IMEKA inc. All other authors declare no conflict of interest.Funding StatementMS is supported by a PhD scholarship from the CIHR. GLi is supported by FRQS UNIQUE postdoctoral scholarship. PT is supported by FRQS J1 salary award and Arthritis Society star career development award. GLe is supported by FRQS J2 salary award.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript https://osf.io/4wyqt/